Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Controlled Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic for Individuals With Suicidal Ideation and/or Suicide Attempts

NCT05144685 is registered in ClinicalTrials.gov with Oui Therapeutics, Inc. as lead sponsor.

NCT NCT05144685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Controlled Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic for Individuals With Suicidal Ideation and/or Suicide Attempts
Lead sponsor
Oui Therapeutics, Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
April 7, 2022
Completion date
June 14, 2024
Enrollment
356 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation, suicide, attempted